Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy.
Fox TA, Troy-Barnes E, Kirkwood AA, Chan WY, Day JW, Chavda SJ, Kumar EA, David K, Tomkins O, Sanchez E, Scully M, Khwaja A, Lambert J, Singer M, Roddie C, Morris EC, Yong KL, Thomson KJ, Ardeshna KM.
Fox TA, et al. Among authors: scully m.
Br J Haematol. 2020 Oct;191(2):194-206. doi: 10.1111/bjh.17027. Epub 2020 Aug 12.
Br J Haematol. 2020.
PMID: 32678948
Free PMC article.